Clinicopathological analysis of CD44 expression in HER2 positive invasive breast cancer

被引：0
|
作者：
Sanaat, Z. [1 ]
Dolatkhah, R. [1 ]
Roosta, Y. [1 ]
Nikhanfar, A. R. [1 ]
Fakhrjou, A. [1 ]
机构：
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
来源：
BREAST | 2019年 / 44卷
关键词：
D O I：
10.1016/S0960-9776(19)30131-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P030
引用
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [1] Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer
    Jang, Min Hye
    Kang, Hyun Jong
    Jang, Ki Seok
    Paik, Seung Sam
    Kim, Wan Seop
    [J]. ONCOLOGY LETTERS, 2016, 12 (04) : 2728 - 2733
  • [2] High Level of CD44 Expression and Soluble CD44 Secretion Mediate Trastuzumab Resistance in HER2 Positive Breast Cancer.
    Jin, Q.
    Baek, J. M.
    Boulbes, D. R.
    Esteva, F. J.
    [J]. CANCER RESEARCH, 2011, 71
  • [3] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Boulbes, Delphine R.
    Chauhan, Gaurav B.
    Jin, Quanri
    Bartholomeusz, Chandra
    Esteva, Francisco J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 501 - 513
  • [4] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Delphine R. Boulbes
    Gaurav B. Chauhan
    Quanri Jin
    Chandra Bartholomeusz
    Francisco J. Esteva
    [J]. Breast Cancer Research and Treatment, 2015, 151 : 501 - 513
  • [5] Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
    Inoue, Kazushi
    Fry, Elizabeth A.
    [J]. GENETICS & EPIGENETICS, 2015, 7 : 19 - 32
  • [6] Tandem peptides targeting HER2 for delivery of CD44 siRNA into HER2+breast cancer cells in vitro
    Kalogeros, James W.
    Miserendino, Audreanna
    Alexander-Bryant, Angela
    Booth, Brian
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [7] Serum CD44 levels and overall survival in patients with HER2-positive breast cancer
    Jong-Min Baek
    Quanri Jin
    Joe Ensor
    Delphine R. Boulbes
    Francisco J. Esteva
    [J]. Breast Cancer Research and Treatment, 2011, 130 : 1029 - 1036
  • [8] Serum CD44 levels and overall survival in patients with HER2-positive breast cancer
    Baek, Jong-Min
    Jin, Quanri
    Ensor, Joe
    Boulbes, Delphine R.
    Esteva, Francisco J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1029 - 1036
  • [9] The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast CD44/CD24 expression in breast cancer
    Kapucuoglu, Nilgun
    Bozkurt, Kemal Kursat
    Baspinar, Sirin
    Kocer, Murat
    Eroglu, Hasan Erol
    Akdeniz, Rasit
    Akcil, Mehtap
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (10) : 740 - 747
  • [10] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345